UnknownNot Applicable

Using Embryo Organoids to Discover Human-specific Mechanisms of Preimplantation Embryo Development and Early Pregnancy

France5 participantsStarted 2022-02-01

Plain-language summary

EMBRYOx study aims to establish and validate the use of trophoblast organoids (embryoids) from trophoblast placental stem cells as a 3D research model in understanding further preimplantation embryo development in vitro. The organoids are capable of proliferation, differentiation, and implantation in a matrix, reproducing early human embryo development.

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: \- No smoking patients without drug consumption or previous medication who are having first trimester voluntary termination of pregnancy surgically or medically induced. Exclusion criteria: \- Patients smoking, drug consumption, previous medication

What they're measuring

Rate of research in preimplantation embryo development in vitro

Timeframe: 1 day

Trial details

NCT IDNCT05231551

SponsorUniversity Hospital, Montpellier

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-02-01

Contact for this trial

Sophie BROUILLET, MCU-PH

.4.67.33.59.54 s-brouillet@chu-montpellier.fr

View on ClinicalTrials.gov More Infertility trials